关注
Bree B. Aldridge
Bree B. Aldridge
Tufts University School of Medicine, Tufts University School of Engineering
在 tufts.edu 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Definitions and guidelines for research on antibiotic persistence
NQ Balaban, S Helaine, K Lewis, M Ackermann, B Aldridge, DI Andersson, ...
Nature Reviews Microbiology 17 (7), 441-448, 2019
10012019
Physicochemical modelling of cell signalling pathways
BB Aldridge, JM Burke, DA Lauffenburger, PK Sorger
Nature cell biology 8 (11), 1195-1203, 2006
7742006
Asymmetry and aging of mycobacterial cells lead to variable growth and antibiotic susceptibility
BB Aldridge, M Fernandez-Suarez, D Heller, V Ambravaneswaran, ...
Science 335 (6064), 100-104, 2012
4752012
Quantitative analysis of pathways controlling extrinsic apoptosis in single cells
JG Albeck, JM Burke, BB Aldridge, M Zhang, DA Lauffenburger, ...
Molecular cell 30 (1), 11-25, 2008
4672008
Fuzzy logic analysis of kinase pathway crosstalk in TNF/EGF/insulin-induced signaling
BB Aldridge, J Saez-Rodriguez, JL Muhlich, PK Sorger, DA Lauffenburger
PLoS computational biology 5 (4), e1000340, 2009
2102009
Misorientation and reduced stretching of aligned sister kinetochores promote chromosome missegregation in EB1‐or APC‐depleted cells
VM Draviam, I Shapiro, B Aldridge, PK Sorger
The EMBO journal 25 (12), 2814-2827, 2006
2072006
Engineered cell and tissue models of pulmonary fibrosis
A Sundarakrishnan, Y Chen, LD Black, BB Aldridge, DL Kaplan
Advanced drug delivery reviews 129, 78-94, 2018
1422018
Efficient measurement and factorization of high-order drug interactions in Mycobacterium tuberculosis
M Cokol, N Kuru, E Bicak, J Larkins-Ford, BB Aldridge
Science advances 3 (10), e1701881, 2017
1242017
Direct Lyapunov exponent analysis enables parametric study of transient signalling governing cell behaviour
BB Aldridge, G Haller, PK Sorger, DA Lauffenburger
IEE Proceedings-Systems Biology 153 (6), 425-432, 2006
912006
Exploitation of Mycobacterium tuberculosis Reporter Strains to Probe the Impact of Vaccination at Sites of Infection
N Sukumar, S Tan, BB Aldridge, DG Russell
PLoS pathogens 10 (9), e1004394, 2014
892014
Microbial metabolomics: innovation, application, insight
BB Aldridge, KY Rhee
Current opinion in microbiology 19, 90-96, 2014
882014
Lyapunov exponents and phase diagrams reveal multi‐factorial control over TRAIL‐induced apoptosis
BB Aldridge, S Gaudet, DA Lauffenburger, PK Sorger
Molecular systems biology 7 (1), 553, 2011
842011
Spatially distinct and metabolically active membrane domain in mycobacteria
JM Hayashi, CY Luo, JA Mayfield, T Hsu, T Fukuda, AL Walfield, ...
Proceedings of the National Academy of Sciences 113 (19), 5400-5405, 2016
782016
Prediction of ultra-high-order antibiotic combinations based on pairwise interactions
I Katzir, M Cokol, BB Aldridge, U Alon
PLoS computational biology 15 (1), e1006774, 2019
682019
Protein complexes and proteolytic activation of the cell wall hydrolase RipA regulate septal resolution in mycobacteria
MC Chao, KJ Kieser, S Minami, D Mavrici, BB Aldridge, SM Fortune, ...
PLoS pathogens 9 (2), e1003197, 2013
682013
A parallel adder coordinates mycobacterial cell-cycle progression and cell-size homeostasis in the context of asymmetric growth and organization
MM Logsdon, PY Ho, K Papavinasasundaram, K Richardson, M Cokol, ...
Current Biology 27 (21), 3367-3374. e7, 2017
662017
Temporal and intrinsic factors of rifampicin tolerance in mycobacteria
K Richardson, OT Bennion, S Tan, AN Hoang, M Cokol, BB Aldridge
Proceedings of the National Academy of Sciences 113 (29), 8302-8307, 2016
522016
Influence of Stress and Antibiotic Resistance on Cell-Length Distribution in Mycobacterium tuberculosis Clinical Isolates
S Vijay, DN Vinh, HT Hai, VTN Ha, VTM Dung, TD Dinh, HN Nhung, ...
Frontiers in microbiology 8, 2296, 2017
442017
Transcriptomic signatures predict regulators of drug synergy and clinical regimen efficacy against tuberculosis
S Ma, S Jaipalli, J Larkins-Ford, J Lohmiller, BB Aldridge, DR Sherman, ...
MBio 10 (6), 10.1128/mbio. 02627-19, 2019
412019
Systematic measurement of combination-drug landscapes to predict in vivo treatment outcomes for tuberculosis
J Larkins-Ford, T Greenstein, N Van, YN Degefu, MC Olson, A Sokolov, ...
Cell Systems 12, 1-18, 2021
402021
系统目前无法执行此操作,请稍后再试。
文章 1–20